Security record · archived quarter
TSHA
Taysha Gene Therapies, Inc. · Healthcare · Biotechnology
16Tracked holders
+5Δ holders
65.80MShares held
$152.01MReported value
+5New positions
−0Exits
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +21.7% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 85 | +6 | 146.63M | $997.83M | +12 | −5 |
| Q1 2026 | 81 | -9 | 130.93M | $584.01M | +4 | −14 |
| Q4 2025 | 90 | 0 | 135.71M | $746.41M | +2 | −1 |
| Q3 2025 | 18 | -1 | 108.64M | $355.25M | — | −1 |
| Q2 2025 | 16 | +5 | 65.80M | $152.01M | +5 | — |
| Q1 2025 | 8 | -4 | 14.26M | $19.83M | +1 | −5 |
| Q4 2024 | 12 | +5 | 19.11M | $33.06M | +5 | — |
| Q3 2024 | 6 | 0 | 7.50M | $15.08M | +2 | −2 |
| Q2 2024 | 6 | — | 5.37M | $12.04M | — | — |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 15.63M | — | $36.10M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 15.63M | — | $36.10M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 15.63M | — | $36.10M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passive) | 13.30M | — | $30.73M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (passive) | 10.89M | — | $25.17M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passive) | 10.89M | — | $25.17M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passive) | 10.89M | — | $25.17M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 7.32M | +60.1% | $16.90M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (passive) | 5.14M | +58.9% | $11.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | Adage Capital Partners ✦ | 4.84M | New | $11.18M | 0.0% | New | 1 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passive) | 3.79M | +3.5% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passive) | 3.79M | +3.5% | $8.77M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Millennium Management ✦ | 2.94M | +65.6% | $6.78M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 635.97K | +1.7% | $1.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Wellington Management ✦ | 635.97K | +1.7% | $1.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | Wellington Management ✦ | 635.97K | +1.7% | $1.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 528.99K | +144.2% | $1.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 401.51K | New | $927,486 | 0.0% | New | 1 | SEC ↗ |
| 26 | AQR Capital Management ✦ | 135.77K | +25.8% | $313,620 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | AQR Capital Management ✦ | 135.77K | +25.8% | $313,620 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 135.77K | +25.8% | $313,620 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 135.77K | +25.8% | $313,620 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 84.60K | +14.3% | $196,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Marshall Wace ✦ | 79.50K | New | $183,640 | 0.0% | New | 1 | SEC ↗ |
| 32 | Marshall Wace ✦ | 79.50K | New | $183,640 | 0.0% | New | 1 | SEC ↗ |
| 33 | Renaissance Technologies ✦ | 54.90K | New | $126,819 | 0.0% | New | 1 | SEC ↗ |
| 34 | Two Sigma Investments ✦ | 32.68K | New | $75,495 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $11.18M | 0.0% |
| D. E. Shaw & Co. | $927,486 | 0.0% |
| Marshall Wace | $183,640 | 0.0% |
| Marshall Wace | $183,640 | 0.0% |
| Renaissance Technologies | $126,819 | 0.0% |
| Two Sigma Investments | $75,495 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 190 holders, 265.00M shares, $1.21B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API